REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW 9,870.00
-40.00 (-0.40%)
Aug 3, 2026, 3:30 PM KST
REYON Pharmaceutical Market Cap
REYON Pharmaceutical has a market cap or net worth of 181.76 billion as of August 3, 2026. Its market cap has decreased by -12.30% in one year.
Market Cap
181.76B
Enterprise Value
396.58B
Revenue
145.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,870.00
ChartMarket Cap Chart
Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 181.76B, an increase of 10.46%. That is a compound annual growth rate of 0.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 181.76B | -8.07% |
| Dec 30, 2025 | 197.72B | -16.04% |
| Dec 30, 2024 | 235.50B | -22.37% |
| Dec 28, 2023 | 303.36B | -21.07% |
| Dec 29, 2022 | 384.35B | -39.10% |
| Dec 30, 2021 | 631.11B | 61.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samjin Pharmaceuticals | 217.33B |
| Yungjin Pharm. | 212.34B |
| Whan In Pharm | 185.76B |
| Chong Kun Dang Holdings | 181.62B |
| Dong Sung Bio Pharm.Co.,Ltd. | 173.31B |
| JW Lifescience | 172.50B |
| FutureChem Co.,Ltd | 170.86B |
| BNC KOREA | 162.10B |